The Duke Department of Medicine recognizes a wide range of faculty research achievements highlighting new federal, foundation and industry-sponsored awards supporting scientific discovery and clinical innovation.
Sponsored Research
Sunag R. Udupa (Mentor: Robert Lefkowitz) of Cardiology has received an award from the American Heart Association for a project entitled "Structural and Mechanistic Basis of ss-arrestin2 Signaling Through the MAPK JNK3." Total funding will be $70,676.
Jonathan Campbell of Endocrinology has received an award from the American Diabetes Association for a project entitled "Beyond glycemia: expanding glucagon biology to water homeostasis." Total funding will be $264,320.
Michael Pignone of General Internal Medicine has received an award from the University of Texas at Austin for a project entitled "CONNECT: developing a colorectal cancer screening plan for Texas." Total funding will be $11,500.
James Wharam of General Internal Medicine has received a sub-award through the Emory University for a project entitled "Impact of Medicare Part D opioid safety policies on disabled beneficiaries before and during the COVID-19 pandemic - Yr. 2." Total funding will be $43,668.
William Yancy of General Internal Medicine has received a sub-award through the University of Washington for a project entitled "Equitable Primary Care for Pain Care." Total funding will be $80,750.
John Strouse of Hematology has received a sub-award through the University of California - San Francisco for a project entitled "Zinc Supplementation in Sickle Cell Disease: A Precursor to `Think Zinc for Bones Trial." Total funding will be $15,210.
Jacqueline Hodges of Infectious Diseases has received a sub-award through the Durham Technical Community College for a project entitled "Project MAPS: Mobile Addiction and Primary Care Services." Total funding will be $38,618.
Carey Anders of Oncology has received a sub-award through the Johns Hopkins University for a project entitled "Aurora US: Prospective Biospecimen Repository in Metastatic Breast Cancer." Total funding will be $34,197.
Carey Anders of Oncology has received a sub-award through the Johns Hopkins University for a project entitled "Translational Breast Cancer Research Consortium 2025 Infrastructure - SGK." Total funding will be $27,000.
Carey Anders of Oncology has received a sub-award through the Johns Hopkins University for a project entitled "Translational Breast Cancer Research Consortium 2025 Infrastructure (BCRF)." Total funding will be $27,000.
Laurie Snyder of Pulmonary has received a sub-award through the University of Pennsylvania for a project entitled "Advanced body composition imaging to improve outcomes in lung transplantation." Total funding will be $48,592.
Industry Sponsored Clinical Trials
Daniel Friedman of Cardiology has received an award from Boston Scientific Corporation for a project entitled "Safety and Effectiveness of Left Bundle Branch Area Pacing versus Conventional Cardiac Resynchronization Therapy in Heart Failure." Total funding will be $398,410.
Marat Fudim of Cardiology has received an award from Pharmacosmos Therapeutics Inc. for a project entitled "A phase III, randomized, open-label, blinded endpoint, comparative trial of ferric derisomaltose versus no intravenous iron in irondeficient subjects with symptomatic chronic heart failure." Total funding will be $268,790.
Svati Shah of Cardiology has received an award from Novo Nordisk A/S for a project entitled "CVD Biomarkers Study (miR-132)." Total funding will be $375,113.
Nicole Jawitz of Gastroenterology has received an award from Sanofi US for a project entitled "Sanofi_EFC18325_Phase 3 Anti-TL1A IBD Program - Ulcerative Colitis Pro00119361." Total funding will be $85,260.
Nicole Jawitz of Gastroenterology has received an award from Sanofi US for a project entitled "Sanofi_EFC18326_Phase 3 Anti-TL1A IBD Program - Crohn's Dx Pro00119061." Total funding will be $85,260.
Maria Segovia of Gastroenterology has received an award from Zealand Pharma A/S for a project entitled "Zealand ZP1848-23029 EASE-5_2US03 A Phase 3, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multicenter Trial to Confirm the Efficacy and Safety of Glepaglutide 10 mg Twice-Weekly, Followed by a Long-Term, Open-Label Safety Evaluation." Total funding will be $10,560.
Grace Lee of Hematology has received a sub-award through Adamas Nanotechnologies, Inc. for a project entitled "Nanodiamond Quantum Sensors for Free Radical Detection." Total funding will be $448,906.
Micah McClain of Infectious Diseases has received a sub-award through Cepheid for a project entitled "Validation of RNA biomarkers for infectious and inflammatory diseases diagnosis." Total funding will be $206,771.
Opeyemi Olabisi of Nephrology has received an award from Alnylam Pharmaceuticals, Inc. for a project entitled "APOL1 Mediated Kidney Disease." Total funding will be $383,674.
Andrew Armstrong of Oncology has received an award from K36 Therapeutics for a project entitled "Phase 1, Dose-Escalation Study of KTX-2001 (an NSD2 Inhibitor) Alone and in Combination with Darolutamide for Metastatic Castration-Resistant Prostate Cancer, K36-MCRPC-001." Total funding will be $497,347.
Daniel George of Oncology has received an award from Pfizer, Inc. for a project entitled "A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MEVROMETOSTAT (PF-06821497) WITH ENZALUTAMIDE IN METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER (MEVPRO-3)." Total funding will be $660,366.
Michael Harrison of Oncology has received an award from Calico Life Sciences LLC for a project entitled "A Phase 1 Study with ABBV-CLS-484 Alone and in Combination in Subjects with Locally Advanced or Metastatic Tumors,"" protocol no. M20-431." Total funding will be $278,802.
Christopher Hoimes of Oncology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label multicenter, Phase II study to assess the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) vs standard." Total funding will be $167,752.
Cameron Oswalt of Oncology has received an award from CatalYm GmbH for a project entitled "A Phase 2, Randomized, Blinded, Placebo-Controlled Trial Investigating the Efficacy and Safety of Visugromab plus Nivolumab with or without Docetaxel versus Docetaxel Monotherapy in Second-Line Treatment of Participants with Metastatic Non-Squamous N." Total funding will be $901,345.
April Salama of Oncology has received an award from Genmab US, Inc. for a project entitled "Efficacy and Safety Study of Acasunlimab as Monotherapy and in Combination With Pembrolizumab in Subjects With Relapsed/Refractory,Unresectable Locally Advanced or Metastatic Cutaneous Melanoma That Progressed On or After Treatment With a Checkpoint." Total funding will be $32,641.
Peter Bressler of Pulmonary has received an award from Blueprint Medicines Corporation for a project entitled "BLU-263-1201 BLUEPRINT HARBOR A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Trial of BLU-263 in Indolent Systemic Mastocytosis Pro00117000." Total funding will be $212,059.
Scott Palmer of Pulmonary has received an award from Sanofi US Services, Inc. for a project entitled "STRIDE Registry." Total funding will be $8,884,794.
Emma R. Trachman (Mentor: David Leverenz) of Rheumatology has received an award from UCB, Inc for a project entitled "Duke Rheumatology Women's Health Fellowship 2025 - 2026." Total funding will be $99,967.
Teresa Tarrant of Rheumatology has received an award from Chiesi USA, Inc for a project entitled "Diagnosis and Monitoring of Purine Metabolic Immunodeficiency Disorders." Total funding will be $1,551,739.